General information about company |
|||
|---|---|---|---|
| Scrip Code | 532540 | ||
| NSE Symbol | TCS | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE467B01029 | ||
| Name of company | Tata Consultancy Services Limited | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 10-Apr-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-Mar-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | Fourth quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 10-Apr-2025 11:30:00 | ||
| End date and time of board meeting | 10-Apr-2025 15:30:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 644790000000 | 2553240000000 | |
| Other income | 10280000000 | 39620000000 | |
| Total income | 655070000000 | 2592860000000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | 0 |
| (b) | Purchases of stock-in-trade | 0 | 0 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | 0 |
| (d) | Employee benefit expense | 367620000000 | 1457880000000 |
| (e) | Finance costs | 2270000000 | 7960000000 |
| (f) | Depreciation, depletion and amortisation expense | 13790000000 | 52420000000 |
| (f) | Other Expenses | ||
| 1 | Cost of equipment and software licences | 27480000000 | 116480000000 |
| 2 | Other expenses | 79890000000 | 304810000000 |
| Total other expenses | 107370000000 | 421290000000 | |
| Total expenses | 491050000000 | 1939550000000 | |
| 3 | Total profit before exceptional items and tax | 164020000000 | 653310000000 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Total profit before tax | 164020000000 | 653310000000 |
| 6 | Tax expense | ||
| 7 | Current tax | 43250000000 | 169100000000 |
| 8 | Deferred tax | -2160000000 | -3760000000 |
| 9 | Total tax expenses | 41090000000 | 165340000000 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | 122930000000 | 487970000000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 16 | Total profit (loss) for period | 122930000000 | 487970000000 |
| 17 | Other comprehensive income net of taxes | 5620000000 | 5890000000 |
| 18 | Total Comprehensive Income for the period | 128550000000 | 493860000000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 122240000000 | 485530000000 | |
| Total profit or loss, attributable to non-controlling interests | 690000000 | 690000000 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 127650000000 | 491240000000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 900000000 | 2620000000 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3620000000 | 3620000000 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 954090000000 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 33.79 | 134.19 | |
| Diluted earnings (loss) per share from continuing operations | 33.79 | 134.19 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 33.79 | 134.19 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 33.79 | 134.19 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 109780000000 | ||
| Capital work-in-progress | 15460000000 | ||
| Investment property | |||
| Goodwill | 18600000000 | ||
| Other intangible assets | 102150000000 | ||
| Intangible assets under development | |||
| Biological assets other than bearer plants | |||
| Investments accounted for using equity method | |||
| Non-current financial assets | |||
| Non-current investments | 2750000000 | ||
| Trade receivables, non-current | 1290000000 | ||
| Loans, non-current | 250000000 | ||
| Other non-current financial assets | 27310000000 | ||
| Total non-current financial assets | 31600000000 | ||
| Deferred tax assets (net) | 35780000000 | ||
| Other non-current assets | 52810000000 | ||
| Total non-current assets | 366180000000 | ||
| 2 | Current assets | ||
| Inventories | 210000000 | ||
| Current financial asset | |||
| Current investments | 306890000000 | ||
| Trade receivables, current | 590460000000 | ||
| Cash and cash equivalents | 83420000000 | ||
| Bank balance other than cash and cash equivalents | 71210000000 | ||
| Loans, current | 90000000 | ||
| Other current financial assets | 27420000000 | ||
| Total current financial assets | 1079490000000 | ||
| Current tax assets (net) | 2570000000 | ||
| Other current assets | 147840000000 | ||
| Total current assets | 1230110000000 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 1596290000000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 3620000000 | ||
| Other equity | 943940000000 | ||
| Total equity attributable to owners of parent | 947560000000 | ||
| Non controlling interest | 10150000000 | ||
| Total equity | 957710000000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 0 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 85180000000 | ||
| Total non-current financial liabilities | 85180000000 | ||
| Provisions, non-current | 0 | ||
| Deferred tax liabilities (net) | 9800000000 | ||
| Deferred government grants, Non-current | |||
| Other non-current liabilities | 13590000000 | ||
| Total non-current liabilities | 108570000000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 0 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 1570000000 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 137520000000 | ||
| Total Trade payable | 139090000000 | ||
| Other current financial liabilities | 100960000000 | ||
| Total current financial liabilities | 240050000000 | ||
| Other current liabilities | 161010000000 | ||
| Provisions, current | 1800000000 | ||
| Current tax liabilities (Net) | 127150000000 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 530010000000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 638580000000 | ||
| Total equity and liabilites | 1596290000000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Banking, Financial Services and Insurance | 242570000000 | 945970000000 | ||||
| 2 | Manufacturing | 63950000000 | 251700000000 | ||||
| 3 | Consumer Business | 101460000000 | 401970000000 | ||||
| 4 | Communication, Media and Technology | 110220000000 | 458930000000 | ||||
| 5 | Life Sciences and Healthcare | 64910000000 | 264560000000 | ||||
| 6 | Others | 61680000000 | 230110000000 | ||||
| Total Segment Revenue | 644790000000 | 2553240000000 | |||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | 644790000000 | 2553240000000 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Banking, Financial Services and Insurance | 63750000000 | 251350000000 | ||||
| 2 | Manufacturing | 20290000000 | 82250000000 | ||||
| 3 | Consumer Business | 29290000000 | 112220000000 | ||||
| 4 | Communication, Media and Technology | 23760000000 | 95820000000 | ||||
| 5 | Life Sciences and Healthcare | 16910000000 | 74480000000 | ||||
| 6 | Others | 15790000000 | 57950000000 | ||||
| Total Profit before tax | 169790000000 | 674070000000 | |||||
| i. Finance cost | 2270000000 | 2270000000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 3500000000 | 3500000000 | |||||
| Profit before tax | 164020000000 | 653310000000 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Banking, Financial Services and Insurance | 0 | 0 | ||||
| 2 | Manufacturing | 0 | 0 | ||||
| 3 | Consumer Business | 0 | 0 | ||||
| 4 | Communication, Media and Technology | 0 | 0 | ||||
| 5 | Life Sciences and Healthcare | 0 | 0 | ||||
| 6 | Others | 0 | 0 | ||||
| Total Segment Asset | 0 | 0 | |||||
| Un-allocable Assets | 0 | 0 | |||||
| Net Segment Asset | 0 | 0 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Banking, Financial Services and Insurance | 0 | 0 | ||||
| 2 | Manufacturing | 0 | 0 | ||||
| 3 | Consumer Business | 0 | 0 | ||||
| 4 | Communication, Media and Technology | 0 | 0 | ||||
| 5 | Life Sciences and Healthcare | 0 | 0 | ||||
| 6 | Others | 0 | 0 | ||||
| Total Segment Liabilities | 0 | 0 | |||||
| Un-allocable Liabilities | 0 | 0 | |||||
| Net Segment Liabilities | 0 | 0 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined employee benefit plans | -1600000000 | -1060000000 |
| 2 | Net change in fair values of investments in equity sharesncarried at fair value through OCI | -60000000 | -240000000 |
| Total Amount of items that will not be reclassified to profit and loss | -1660000000 | -1300000000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -400000000 | -180000000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Net change in fair values of investments other than nequity shares carried at fair value through OCI | 2800000000 | 5930000000 |
| 2 | Net change in intrinsic value of derivatives designated asncash flow hedges | -180000000 | 10000000 |
| 3 | Net change in time value of derivatives designated as ncash flow hedges | -100000000 | -90000000 |
| 4 | Exchange differences on translation of financial statementsnof foreign operations | 5000000000 | 2620000000 |
| Total Amount of items that will be reclassified to profit and loss | 7520000000 | 8470000000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 640000000 | 1460000000 |
| 5 | Total Other comprehensive income | 5620000000 | 5890000000 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 2024-04-01 | ||||
| B | Date of end of reporting period | 2025-03-31 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 653310000000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 7960000000 | |||||
| Adjustments for decrease (increase) in inventories | 70000000 | |||||
| Adjustments for decrease (increase) in trade receivables, current | -52280000000 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | -25520000000 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0 | |||||
| Adjustments for other financial assets, non-current | 0 | |||||
| Adjustments for other financial assets, current | -7380000000 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | 37180000000 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 15530000000 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 52420000000 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 0 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | -1190000000 | |||||
| Adjustments for other financial liabilities, non-current | 0 | |||||
| Adjustments for unrealised foreign exchange losses gains | -10000000 | |||||
| Adjustments for dividend income | 430000000 | |||||
| Adjustments for interest income | 32960000000 | |||||
| Adjustments for share-based payments | 0 | |||||
| Adjustments for fair value losses (gains) | 0 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | -2890000000 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | 1130000000 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | -8370000000 | |||||
| Net cash flows from (used in) operations | 644940000000 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 155860000000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 489080000000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 10630000000 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 230000000 | |||||
| Purchase of property, plant and equipment | 29170000000 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 10200000000 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 290000000 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 30000000 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 400000000 | |||||
| Interest received | 30560000000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -4110000000 | |||||
| Net cash flows from (used in) investing activities | -23180000000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 280000000 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 0 | |||||
| Repayments of borrowings | 0 | |||||
| Payments of lease liabilities | 16640000000 | |||||
| Dividends paid | 449620000000 | |||||
| Interest paid | 8400000000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -474380000000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -8480000000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 1740000000 | |||||
| Net increase (decrease) in cash and cash equivalents | -6740000000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 90160000000 | |||||
| Cash and cash equivalents cash flow statement at end of period | 83420000000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | BSR and Co LLP | Yes | 31-Jul-2025 | ||
|---|---|---|---|---|---|
Financial details |
|||
| Sr. | Particulars | Audited Figures (as reported before adjusting for qualifications) | Adjusted Figures (audited figures after adjusting for qualifications) |
| 1 | Turnover / Total income | ||
| 2 | Total Expenditure | ||
| 3 | Net Profit/(Loss) | ||
| 4 | Earnings Per Share | ||
| 5 | Total Assets | ||
| 6 | Total Liabilities | ||
| 7 | Net Worth | ||
Signatories detail |
|
|---|---|
| Name of CEO / Managing director | |
| Name of CFO | |
| Name of audit committee chairman | |
| Name of statutory auditor | |
| Name of other signatory, if any, with designation | |
| Place | |
| Date | |